Do We “Do No Harm” in the Management of Acute Cholecystitis in COVID-19 Patients?

The diversity in responses by the surgical community and uncertainty regarding the management of acute cholecystitis highlights the challenges we face during this pandemic. Because COVID-19 can significantly complicate the perioperative course, the decision of whether or not to operate on these pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American surgeon 2020-07, Vol.86 (7), p.748-750
Hauptverfasser: F. Narvaez, J. Reinier, Cooper, Clairice, Brewer, Jeffrey J., Schwaitzberg, Steven D., Guo, Weidun Alan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The diversity in responses by the surgical community and uncertainty regarding the management of acute cholecystitis highlights the challenges we face during this pandemic. Because COVID-19 can significantly complicate the perioperative course, the decision of whether or not to operate on these patients/carriers with acute cholecystitis has become complex. [...]it may be more reasonable to consider cholecystectomy for acute cholecystitis as we would prior to the COVID-19 crisis. [...]far, there is no high-quality data supporting the definitive role of cholecystostomy tube in the treatment of acute calculous cholecystitis. [...]the decision to pursue the treatment of acute cholecystitis in COVID-19 patients must be made with the principle of primum non nocere in mind.
ISSN:0003-1348
1555-9823
DOI:10.1177/0003134820939881